Adequate 0 8 0 8 O
pulmonary 9 18 9 18 O
function 19 27 19 27 O
with 28 32 28 32 O
FEV1 33 37 33 37 B-clinical_variable
, 37 38 37 38 O
FVC 39 42 39 42 B-clinical_variable
and 43 46 43 46 O
DLCO 47 51 47 51 B-clinical_variable
> 52 53 52 53 O
/=50 53 57 53 57 O
% 57 58 57 58 I-lower_bound
of 59 61 59 61 O
expected 62 70 62 70 O
corrected 71 80 71 80 O
for 81 84 81 84 O
hemoglobin 85 95 85 95 B-clinical_variable
and/or 96 102 96 102 O
volume 103 109 103 109 O

Children 0 8 110 118 O
unable 9 15 119 125 O
to 16 18 126 128 O
perform 19 26 129 136 O
pulmonary 27 36 137 146 O
function 37 45 147 155 O
tests 46 51 156 161 O
( 52 53 162 163 O
e.g. 53 57 163 167 O
, 57 58 167 168 O
less 59 63 169 173 O
than 64 68 174 178 O
7 69 70 179 180 B-upper_bound
years 71 76 181 186 I-upper_bound
old 77 80 187 190 O
) 80 81 190 191 O
pulse 82 87 192 197 B-clinical_variable
oximetry 88 96 198 206 I-clinical_variable
of 97 99 207 209 O
> 100 101 210 211 O
/= 101 103 211 213 O
92 104 106 214 216 B-lower_bound
% 106 107 216 217 I-lower_bound
on 108 110 218 220 O
room 111 115 221 225 O
air 116 119 226 229 O

Diagnoses 0 9 230 239 O
to 10 12 240 242 O
be 13 15 243 245 O
included 16 24 246 254 O
a 25 26 255 256 O
) 26 27 256 257 O
Acute 28 33 258 263 B-cancer
myeloid 34 41 264 271 I-cancer
leukemia 42 50 272 280 I-cancer
; 50 51 280 281 O
b 52 53 282 283 O
) 53 54 283 284 O
Acute 55 60 285 290 B-cancer
lymphocytic 61 72 291 302 I-cancer
leukemia 73 81 303 311 I-cancer
; 81 82 311 312 O
c 83 84 313 314 O
) 84 85 314 315 O
Chronic 86 93 316 323 B-cancer
myeloid 94 101 324 331 I-cancer
leukemia 102 110 332 340 I-cancer
; 110 111 340 341 O
d 112 113 342 343 O
) 113 114 343 344 O
Chronic 115 122 345 352 B-chronic_disease
lymphoproliferative 123 142 353 372 I-chronic_disease
disorder 143 151 373 381 I-chronic_disease
; 151 152 381 382 O
e 153 154 383 384 O
) 154 155 384 385 O
Myelodysplastic 156 171 386 401 B-cancer
syndrome 172 180 402 410 I-cancer
; 180 181 410 411 O
f 182 183 412 413 O
) 183 184 413 414 O
Myeloproliferative 185 203 415 433 B-cancer
syndromes 204 213 434 443 I-cancer
; 213 214 443 444 O
g 215 216 445 446 O
) 216 217 446 447 O
Non 218 221 448 451 B-cancer
- 221 222 451 452 I-cancer
Hodgkin 222 229 452 459 I-cancer
's 229 231 459 461 I-cancer
lymphoma 232 240 462 470 I-cancer
; 240 241 470 471 O
h 242 243 472 473 O
) 243 244 473 474 O
Hodgkin 245 252 475 482 B-cancer
's 252 254 482 484 I-cancer
Lymphoma 255 263 485 493 I-cancer
; 263 264 493 494 O
i 265 266 495 496 O
) 266 267 496 497 O
Multiple 268 276 498 506 B-cancer
myeloma 277 284 507 514 I-cancer

Left 0 4 515 519 B-clinical_variable
ventricular 5 16 520 531 I-clinical_variable
ejection 17 25 532 540 I-clinical_variable
fraction 26 34 541 549 I-clinical_variable
> 35 36 550 551 O
/= 36 38 551 553 O
50 39 41 554 556 B-lower_bound
% 41 42 556 557 I-lower_bound

Patients 0 8 558 566 O
must 9 13 567 571 O
have 14 18 572 576 O
a 19 20 577 578 O
haploidentical 21 35 579 593 B-treatment
related 36 43 594 601 O
donor 44 49 602 607 O
or 50 52 608 610 O
a 53 54 611 612 O
fully 55 60 613 618 O
matched 61 68 619 626 O
related 69 76 627 634 O
or 77 79 635 637 O
unrelated 80 89 638 647 O
donor 90 95 648 653 O

Patients 0 8 654 662 O
with 9 13 663 667 O
active 14 20 668 674 O
Hepatitis 21 30 675 684 B-chronic_disease
B 31 32 685 686 I-chronic_disease
and 33 36 687 690 I-chronic_disease
C 37 38 691 692 I-chronic_disease

Patients 0 8 693 701 O
with 9 13 702 706 O
high 14 18 707 711 O
- 18 19 711 712 O
risk 19 23 712 716 O
hematologic 24 35 717 728 B-cancer
malignancies 36 48 729 741 I-cancer
with 49 53 742 746 O
anticipated 54 65 747 758 O
poor 66 70 759 763 O
prognosis 71 80 764 773 O
with 81 85 774 778 O
non 86 89 779 782 B-treatment
transplant 90 100 783 793 I-treatment
therapy 101 108 794 801 I-treatment
, 108 109 801 802 O
including 110 119 803 812 O
those 120 125 813 818 O
in 126 128 819 821 O
remission 129 138 822 831 O
or 139 141 832 834 O
with 142 146 835 839 O
induction 147 156 840 849 O
failure 157 164 850 857 O
and 165 168 858 861 O
after 169 174 862 867 O
treated 175 182 868 875 O
or 183 185 876 878 O
untreated 186 195 879 888 O
relapse 196 203 889 896 O

Performance 0 11 897 908 B-clinical_variable
score 12 17 909 914 I-clinical_variable
of 18 20 915 917 O
> 21 22 918 919 O
/= 22 24 919 921 O
70 25 27 922 924 B-lower_bound
by 28 30 925 927 O
Karnofsky 31 40 928 937 B-clinical_variable
/ 40 41 937 938 I-clinical_variable
Lansky 41 47 938 944 I-clinical_variable
or 48 50 945 947 I-clinical_variable
PS 51 53 948 950 I-clinical_variable
0 54 55 951 952 O
to 56 58 953 955 O
1 59 60 956 957 B-upper_bound
( 61 62 958 959 O
ECOG 62 66 959 963 B-clinical_variable
< 67 68 964 965 O
/=1 68 71 965 968 O
) 71 72 968 969 O

Prior 0 5 970 975 B-treatment
allogeneic 6 16 976 986 I-treatment
transplant 17 27 987 997 I-treatment

SGPT 0 4 998 1002 B-clinical_variable
( 5 6 1003 1004 I-clinical_variable
ALT 6 9 1004 1007 I-clinical_variable
) 9 10 1007 1008 I-clinical_variable
< 11 12 1009 1010 O
200 13 16 1011 1014 B-upper_bound

Uncontrolled 0 12 1015 1027 B-chronic_disease
infections 13 23 1028 1038 I-chronic_disease

Women 0 5 1039 1044 B-gender
of 6 8 1045 1047 O
child 9 14 1048 1053 O
bearing 15 22 1054 1061 O
potential 23 32 1062 1071 O
must 33 37 1072 1076 O
be 38 40 1077 1079 O
willing 41 48 1080 1087 B-contraception_consent
to 49 51 1088 1090 I-contraception_consent
use 52 55 1091 1094 I-contraception_consent
an 56 58 1095 1097 I-contraception_consent
effective 59 68 1098 1107 I-contraception_consent
contraceptive 69 82 1108 1121 I-contraception_consent
measure 83 90 1122 1129 I-contraception_consent
while 91 96 1130 1135 O
on 97 99 1136 1138 O
study 100 105 1139 1144 O

